Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery;Procalcitoninplasmakonzentration und systemische inflammatorische antwort nach verschiedenen operativen eingriffen

Anaesthesist

Volumn 52, Issue 3, 2003, Pages 210-217

  Molter, G P ^a   Soltesz S ^a   Kottke, R ^b   Wilhelm, W ^b   Biedler, A ^b   Silomon, M ^b  

^a KLINIKUM LEVERKUSEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

C reactive protein; Calcitonin; SIRS; Surgery

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ABDOMINAL SURGERY; ARTICLE; BACTERIAL INFECTION; ESOPHAGUS RESECTION; HALF LIFE TIME; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; MAJOR CLINICAL STUDY; MYCOSIS; PARASITOSIS; PATIENT MONITORING; POSTOPERATIVE CARE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX SURGERY; VASCULAR SURGERY; ABDOMEN; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; POSTOPERATIVE COMPLICATION;

ABDOMEN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; POSTOPERATIVE COMPLICATIONS; PROTEIN PRECURSORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORACIC SURGICAL PROCEDURES; VASCULAR SURGICAL PROCEDURES;

EID: 0037360433     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0460-8     Document Type: Article

References (35)

1. Al-Nawas B, Krammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331-333
2. American College of Chest Physicians/Society of Critical Care Medicine (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
3. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, Rousson R, Evans R, Lehot JJ (1999) Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth: 83:602-607
4. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentration in patients with sepsis and infection. Lancet 341:515-518
5. Bach F, Grundmann U, Bauer M, Buchinger H, Soltész S, Graeter T, Larsen R, Silomon M (2002) Modulation of inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia. Acta Anaesthesiol Scand 46:1227-1235
6. Bohuon C (2000) A brief history of procalcitonin. Intensive Care Med 26:S146-S147
7. Boralessa A, De Beer FC, Manchie A, Whitham JG, Pepys MB (1986) C-reactive protein in patients undergoing cardiac surgery. Anaesthesia: 41:11-15
8. BRAHMS PCT®-Q Immunographischer Test zum Nachweis von PCT (Procalcitonin) in Serum und Plasma, Version R01 (1999) Brahms-AG, D-16761 Hennigsdorf
9. Brunkhorst FM, Forycki ZF, Wagner J (1995) Procalcitonin immunoreactivity in severe human shock. Intensive Care Med 21 [Suppl] 1:12
10. Carsin H, Assicot M, Feger F, Olivier R, Pennacino I, Le Bever H, Ainaud P, Bohuon C (1997) Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF-α and endotoxin levels early after thermal injury. Burns 23:218-224
11. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohoun C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608
12. Engelmann L, Gundelach K, Pilz U, Werner M (1997) Procalcitonin and its relationship to endotoxin (ETX) in sepsis. Intensive Care Med 23 [Suppl] 1:680
13. Hensel M, Volk T, Döcke WD, Kern F, Tschirna D, Egerer K, Konertz W, Kox WJ (1998) Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 89:93-104
14. Kilger E, Pichler B, Goetz AE et al. (1998) Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 46:130-133
15. Kretzschmar M, Kruger A, Schirrmeister W (2001) Procalcitonin following elective partial liver resection origin from the liver? Acta Anaesthesiol Scand 45:1162-1167
16. Marnitz R, Gramm HJ, Zimmermann J (1997) Elaboration of mediators of inflammatory response after major surgery. Shock 7 [Suppl 2]:124
17. Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323:17-29
18. Meisner M, Tschaikowsky K, Beier W, Schüttler J (1996) Procalcitonin (PCT) ein neuer Parameter zur Diagnose und Verlaufskontrolle von bakteriellen Entzündungen und Sepsis. Anaesthesiol Intensivmed 37:529-539
19. Meisner M, Tschaikowsky K, Schmidt J, Schüttler J (1996) Procalcitonin (PCT). Indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovasc Eng 1:67-76
20. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680-684
21. Meisner M, Müller V, Khakpour Z, Toegel E, Redl H (2002) Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock: in press
22. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaikowsky K (2002) Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 28:1094-1102
23. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J (1997) Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 86:209-212
24. Monneret G, Laroche B, Bienvenu J (1999) Procalcitonin is not produced by circulating blood cells. Infection 27:34-35
25. Nijsten MW, Olinga P, The TH, Vries EG de, Koops HS, Groothuis GM, Limburg PC, Duis HJ ten, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH (2000) Procalcitonin behaves as fast responding acute phase protein in vivo and in vitro. Crit Care Med 28:458-461
26. Nylén ES, Snider RH, Thompson KA, Rohatgi P, Becker KL (1996) Pneumonitis-associated hyperprocalcitonemia. Am J Med Sci 312:12-18
27. Oberhoffer M, Bogel D, Meier-Hellmann A, Vogelsang H, Reinhart K (1996) Procalcitonin is higher in non survivors during the clinical course of sepsis,severe sepsis and septic shock. Intensive Care Med 22:A245
28. Oberhoffer M, Stonans I, Russwurm S, Stonane E,Vogelsang H, Junker U, Jäger L, Reinhart K (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro. J Lab Clin Med 134:49-54
29. Pahlke K, Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K (1997) Procalcitonin Eigenschaften eines neuen Parameters bei schweren bakteriellen Infektionen und Sepsis. Intensivmedizin 34:381-387
30. Petitjean S, Mackensen A, Engelhardt R, Bohuon C, Assicot M (1994) Induction de la procalcitonine circulante après administration intraveineuse d'endotoxine chez l'homme. Acta Pharm Biol Clin 1:265-268
31. Redl H, Schießer A, Tögel E, Assicot M, Bohuon C (2001) Possible role of procalcitonin release in baboon model of sepsis. Shock 16:25-27
32. Silomon M, Bach F, Ecker D, Graeter T, Grundmann U, Larsen R (1999) Procalcitonin nach extrakorporaler Zirkulation - Synthese im Hepatosplanchnikusgebiet? Anaesthesist 48: 395-398
33. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498-504
34. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W (2000) Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28:950-957
35. Whang KT, Vath SD, Becker KL, Nylen ES, Muller B, Li Q,Tamarkin L,White JC (1999) PCT and proinflammatory cytokine in interactions in sepsis. Shock 12:268-273